MedPath

Susceptibility to High Altitude Pulmonary Edema in Subjects With Increased Hypoxic Pulmonary Vasoconstriction

Not Applicable
Completed
Conditions
High Altitude Pulmonary Edema
Registration Number
NCT00559442
Lead Sponsor
Heidelberg University
Brief Summary

It has been shown, that subjects susceptible to high altitude pulmonary edema (HAPE)are characterized by an abnormal increase of pulmonary artery pressure at rest in hypoxia and during exercise in normoxia. This abnormal rise of pulmonary artery pressure has also been observed in about 10 % of otherwise healthy subjects without prior altitude exposure. The aim of the study is to investigate the susceptibility to HAPE in unacclimatized subjects with abnormal increase of pulmonary artery pressure at rest in hypoxia and during exercise in normoxia after rapid ascent to high altitude (4559 m).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • abnormal increase of pulmonary artery pressure at rest in hypoxia and during exercise in normoxia
  • ability to climb Margherita Hut
Exclusion Criteria
  • Birth at or above 1500 m altitude
  • any cardiovascular or pulmonary disease
  • Infection disease
  • Intake of drugs, in particular Acetazolamide, Nifedipine, corticosteroids or PDE-5-inhibitors.
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Frequency of HAPE after rapid ascent to 4559 mduring the 48 h stay at altitude
Secondary Outcome Measures
NameTimeMethod
Time course of pulmonary artery pressureduring the 48 h stay at altitude
Assessment of right ventricular function by echocardiographyduring the 48 h stay at altitude

Trial Locations

Locations (1)

Sports Medicine, University Hospital

🇩🇪

Heidelberg, Germany

© Copyright 2025. All Rights Reserved by MedPath